# Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

> **NCT00343395** · PHASE4 · TERMINATED · sponsor: **Intermountain Health Care, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** AVANDAMET

## Key facts

- **NCT ID:** NCT00343395
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2007-11
- **Final completion:** 2008-01
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** FDA concerns regarding Avandamet
- **Last updated:** 2011-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343395, "Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00343395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*